Knowledge Hub
Dr. R. Brahmananda Reddy
6 April 2026

Imagine a fire burning inside your blood vessels — not the kind you can feel, but one that quietly damages arterial walls, destabilizes plaques, and sets the stage for heart attacks and strokes. This is chronic systemic inflammation, and for decades, we lacked a simple way to measure it.
Then came high-sensitivity C-reactive protein (hs-CRP).
C-reactive protein is produced by the liver in response to inflammation anywhere in the body. The "high-sensitivity" assay detects it at very low concentrations — levels that a standard CRP test would miss entirely. This sensitivity makes hs-CRP particularly useful for assessing low-grade chronic inflammation, the kind that drives cardiovascular disease over years and decades.
The evidence for hs-CRP as a cardiovascular risk predictor is robust and extensive:
The landmark JUPITER trial (2008) demonstrated that individuals with elevated hs-CRP — even those with normal LDL cholesterol — had significantly elevated cardiovascular risk. Treating these patients with statins reduced both hs-CRP and cardiovascular events by nearly 50%.
A 2020 meta-analysis in the European Heart Journal encompassing over 160,000 participants confirmed that hs-CRP independently predicts cardiovascular events, stroke, and all-cause mortality even after adjusting for traditional risk factors like age, blood pressure, cholesterol, and smoking.
The American Heart Association classifies cardiovascular risk based on hs-CRP levels: below 1.0 mg/L is low risk, 1.0-3.0 mg/L is moderate risk, and above 3.0 mg/L is high risk.
The implications of hs-CRP extend well beyond the heart. Elevated levels have been associated with increased risk of type 2 diabetes, cognitive decline, cancer, and accelerated biological aging. In the longevity framework, hs-CRP is essentially a systemic aging accelerator marker.
Chronic inflammation is considered one of the twelve hallmarks of aging. When hs-CRP is persistently elevated, it signals that your immune system is in a state of constant low-grade activation — burning through resources, damaging tissues, and promoting the very diseases that shorten healthspan.
Numerous factors contribute to elevated hs-CRP: visceral adiposity (belly fat is an inflammatory organ), poor sleep quality, chronic stress, sedentary behavior, smoking, excessive alcohol, ultra-processed diets, and untreated infections or autoimmune conditions.
The good news: hs-CRP is highly responsive to lifestyle interventions. Regular exercise, weight loss (particularly visceral fat reduction), Mediterranean-style diets, omega-3 fatty acids, and stress reduction have all been shown to meaningfully lower hs-CRP levels.
At GenoRyx, hs-CRP is a standard inclusion in every biomarker panel we order. We consider it non-negotiable. If your last health checkup did not include hs-CRP, you are missing one of the most powerful and inexpensive windows into your inflammatory status and cardiovascular trajectory. Book a consultation and let us check the fire you cannot feel.
Book your 400+ biomarker assessment — physician consultation included.
Schedule a consultationReady to know your numbers?
Schedule your consultation with our longevity physician team.
Book Your AssessmentWritten by
UK-trained physician and founder of Genoryx. Writes about longevity medicine, healthspan optimization, and evidence-based wellness.
View profile →
Learn why wearable VO2 Max data can be misleading. Discover how clinical VO2 Max testing in Hyderabad provides precision data for longevity and performance.

Your Apple Watch tracks your heart rate continuously. Your blood test measures it once a year. Both data streams have value, but neither tells the complete story alone.